Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSAD: Prednisone in Atopic Dermatitis
NCT02908698Terminated
- Sponsor
- McMaster University
- Start
- Jan 2017
- Primary completion
- Aug 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of prednisone in atopic dermatitis (AD), sponsored by McMaster University. Primary endpoint: Late Cutaneous Response at Day 9. Started Jan 2017; status: terminated.
02
Drugs
prednisone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02908698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02908698.